Summary
Viruses are ubiquitous and cause numerous infections in humans. These may vary from asymptomatic infection to severe debilitating illness. Viruses enter the host cells to replicate, using host synthetic mechanisms, and, thus, are resistant to conventional antibiotics. The human body responds to viral infection by synthesising specific antibody which can be used to aid diagnosis. Infectious mononucleosis (glandular fever) commonly affects the 15 to 30 years age group. It may produce severe debility which may last a month or more. Coxsackie virus infection can produce symptoms of the common cold but may also invade heart muscle and produce myocarditis, a potentially serious disease. Other viruses also produce a wide spectrum of disease.
Recent evidence has shown that people undergoing severe mental or physical stress may have reduced immunity to viral infections. There are risks associated with strenuous physical activity during the acute phase of viral infection, and there are reports of sudden death and serious complications occurring in previously fit young adults who undertake vigorous exercise when in the acute phase of a viral illness. Abnormalities of skeletal muscle have been demonstrated in patients with viral infection and this may explain the loss of performance experienced by athletes after upper respiratory tract infection.
As a general rule, for all but mild common colds, it is advised that the athlete avoids hard training for the first month after infection.
Article PDF
Similar content being viewed by others
References
Arnold DL, Bone PJ, Radda GK, Taylor DJ. Excessive intracellular acidosis of skeletal muscle on exercise in a patient with post viral exhaustion syndrome. Lancet 1: 1367–1369, 1984
Astrom E, Friman G, Pilstrom L. Effect of viral and mycoplasma infections on ultrastructure and enzyme activities in human skeletal muscle. Acta Pathologica Microbiologica et Immu-nologica Scandinavica (Section A) 84: 113–122, 1976
Behan PO, Behan WMH. Epidemic myalgic Encephalomyelitis. In Rose FC (Ed.) Clinical Neuroepidemiology, pp.374–383, Pitman Medical, Tunbridge Wells, 1980
Beneson AS. Acute viral respiratory disease in control of communicable diseases in man, pp. 262–266, American Public Health Association, Washington, 1975
Bolden KJ. Corticosteroids in the treatment of infectious mononucleosis. Journal of the Royal College of General Practitioners 22: 87–95, 1972
Bullock K, Moore RY. Nucleus ambiguous projections of the thymus gland: possible pathways for regulation of the immune response and the neuro-endocrine network. (Abstract.) Anatomy Records 196: 25, 1980
Burch GE. Viral diseases of the heart. Acta Cardiologica 1: 5–9, 1979
Busse WW. Decreased granulocyte response to isoprotenerol in asthma during upper respiratory infections. American Review of Respiratory Diseases 115: 783–790, 1978
Chretien JH, Esswein JG, Holland WG, et al. Predictions of the duration of infectious mononucleosis. Southern Medical Journal 70: 437–439, 1977
Dalrymple W. Infectious mononucleosis and athletic participation. Journal of the American College Health Association 14/ 15: 257–259, 1965
Dorian B, Keystone W, Garfunkel PE, Brown G. Immune mechanisms in acute psychological stress. (Abstract.) Psychosomatic Medicine 43: 84, 1981.
Domes R, Ter Meulen V. Specificity of IgM antibodies in acute human Coxsackie virus B infections analysed by indirect solid phase enzyme immune assay and Immunoblot technique. Journal of General Virology 64: 159–167, 1983
Douglas DJ, Hanson PG. Upper respiratory infections in the conditioned athlete. Medicine and Science in Sports 10: 55, 1978
Downey H, McKinley CA. Acute lymphadenosis compared with acute lymphatic leukaemia. Archives of Internal Medicine 32: 82–112, 1923
Durham SR, Kay AB. Eosinophils, bronchial hyper-reactivity and late-phase reactions. Clinical Allergy 15: 411–418, 1985
Edmond RTD. Infectious mononucleosis. Medicine 2: 85–87, 1975
Empey DW, Laitinen LA, Jacob SL, Gold WM, Nadel JA. Mechanisms of bronchial hyper-reactivity in normal subjects after upper respiratory tract infections. American Review of Respiratory Diseases 113: 131–139, 1976
Friman G. Effect of acute infectious disease on isometric muscle strength. Scandinavian Journal of Clinical Laboratory Investigation 37: 303–308, 1977
Friman G, Wright JE, Ilback NE, Beisel WR, White JD, et al. Does fever or myalgia indicate reduced physical performance capacity in viral infections. Acta Medica Scandinavica 217: 353–361, 1985
Grist NR, Bell EJ, Assaad F. Enteroviruses in human disease. Progress in Medical Virology 24: 114–157, 1978
Hamblin TJ, Hussein J, Akbar AN, Tang YC, Smith JL, et al. Immunological reason for chronic ill-health after infectious mononucleosis. British Medical Journal 287: 85–88, 1983
Henle W, Henle GE, Horwitz CA. Epstein-Barr virus specific diagnostic tests in infectious mononucleosis. Human Pathology 5: 551–554, 1974
Hoagland RJ. Infectious mononucleosis, Grune and Straton, New York, 1967
Jeammott JB, Borysenko JZ, Borysenko M, McClelland DC, Chapman R, et al. Academic stress, power motivation and decrease in secretion rate of salivary secretory IgA. Lancet 1: 1400–1402, 1983
Jokl E, McClellan JT. Exercise and Cardiac Death. University Park Press, Balitmore, 1971
Jones JF, Ray G, Minnich LL, Hicks MJ, Kibler R, et al. Evidence of active Epstein-Barr virus infection in patients with persistent unexplained illness: elevated anti-early antigen antibodies. Annals of Internal Medicine 102: 1–7, 1985
Kardel T, Holm HH, Rasmussen SN, Mortensen T. Ultrasonic determination of liver and spleen volumes. Scandinavian Journal of Clinical Laboratory Investigation 27: 123–127, 1971
Lakic J. Use of cephalexin to treat glandular fever: a pilot study. British Medical Journal 286: 1617–1618, 1983
Lau RCH. Coxsackie B virus infections in New Zealand patients with cardiac and non-cardiac diseases. Journal of Medical Virology 11: 131–137, 1983
Lehane DE. A sero-epidemiologic study of infectious mononucleosis. The development of EB virus antibody in a military population. Journal of the American Medical Association 212: 2240–2242, 1970
Maki DG, Reich RM. Infectious mononucleosis in the athlete: diagnosis complications and management. American Journal of Sports Medicine 10: 162–173, 1982
McKenzie H, Parrat D, White RG. IgM and IgG antibody levels to ampicillin in patients with infectious mononucleosis. Clinical Experimental Immunology 26: 214–221, 1986
McNeill RS, Nairn JR, Millar JS, Ingram CC. Exercise induced asthma. Quarterly Journal of Medicine 35: 55–67, 1966
Mumford JA, Rossdale PD. Virus and its relationship to the ‘poor performance syndrome’. Equine Veterinary Journal 12: 3–9, 1980
Neiderman JC, McCollum RW, Henle G, et al. Infectious mononucleosis: clinical manifestations in relation to EB virus antibodies. Journal of the American Medical Association 203: 139–142, 1968
Pether JVS. Bacterial meningitis after influenza. Lancet 1: 804, 1982
Powell DG, Burrows R, Spooner P, Goodridge D, Thomson GR, et al. A study of infectious respiratory diseases among horses in Great Britain 1971–76. 4th International Conference of Equine Infectious Diseases, pp.451–460, 1978
Reyes MP, Lerner AM. Interferon and neutralising antibody in sera of exercised mice with Cocksackie B3 myocarditis. Proceedings of the Society for Experimental Biology and Medicine 151: 333–338, 1976
Riemenschneider PA, Whalen JP. The relative accuracy of estimation of enlargement of the liver and spleen by radiographic and clinical methods. American Journal of Radiology 94: 462–468, 1965
Roberts J A. Loss of form in young athletes due to viral infection. British Medical Journal 290: 357–358, 1985
Rutkow IM. Rupture of the spleen in infectious mononucleosis: a critical review. Archives of Surgery 113: 718–720, 1978
Ryan AJ, Evans AS, Hoagland RJ, et al. Infectious mononucleosis in athletes. Physician and Sportsmedicine 6: 40, 1978
Shields CE. How I manage infectious mononucleosis. The Physician and Sportsmedicine 11: 57–59, 1983
Simon HB. The immunology of exercise. Journal of the American Association 292: 2735–2738, 1984
Smith WG. Adult heart disease due to Coxsackie virus group B. British Heart Journal 28: 204–208, 1966
Straus SE, Tosato G, Armstrong G, Lawley T, Preble OT, et al. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Annals of Internal Medicine 102: 7–17, 1985
Sutton GC, Harding HB, Trueheart RP, Clark HP. Coxsackie B4 myocarditis in an adult: successful isolation of virus from ventricular myocardium. Aerospace Medicine 38: 66–69, 1967
Thomasi TB, Trudeau FB, Czerwinski D, Erredge S. Immune parameters in athletes before and after strenuous exercise. Journal of Clinical Immunology 2: 173–178, 1982
Tobi M, Morag A, Ravid Z, Chowers I, Feldman-Weiss V, et al. Prolonged atypical illness associated with serological evidence of persistent EB virus infection. Lancet 1: 61–64, 1982
Williams JM, Peterson RG, Shea PA, Schmedtje JF, Bauer DC, et al. Sympathetic innervation of murine thymus and spleen. Evidence for a functional link between the nervous and immune systems. Brain Research Bulletin 6: 83–94, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roberts, J.A. Viral Illnesses and Sports Performance. Sports Medicine 3, 296–303 (1986). https://doi.org/10.2165/00007256-198603040-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00007256-198603040-00006